Abstract
bcl-2 and p53 gene products have been both linked to programmed cell death pathways. We have analyzed several human breast cancer cell lines for the expression of bcl-2 and p53. We found an inverse correlation between the expression of the two proteins. The result suggested that mutant p53 could substitute for bcl-2 function in breast cancer cells and that could also down-regulate bcl-2 expression. We found, indeed, that overexpression of a mutant p53 (mut 175) in MCF-7 cells could induce down-regulation of bcl-2 both at protein and mRNA level. However, the promoter region of the human bcl-2 gene does not contain the negative regulatory element responsible for the down-regulation. If this mechanism will be proved also for the wild-type p53 allele, it may disclose a possible mechanism for p53-induced apoptosis: down-regulation of bcl-2. © 1994, American Association for Cancer Research. All rights reserved.
Cite
CITATION STYLE
Haldar, S., Negrini, M., Monne, M., Sabbioni, S., & Croce, C. M. (1994). Down-Regulation of bcl-2 by p53 in Breast Cancer Cells. Cancer Research, 54(8), 2095–2097.
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.